Showing results (351-360 of 966) with videos related to
Sort By:
Pageof 97
Nature Reviews. Clinical Oncology|January 6, 2025
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questionsYibei Wang, Mohammed Safi, Fred R Hirsch, et al.Nature Reviews. Clinical Oncology|December 3, 2024
Synthetic lethal strategies for the development of cancer therapeuticsNatalie Y L Ngoi, David Gallo, Carlos Torrado, et al.Nature Reviews. Clinical Oncology|October 4, 2024
The high costs of anticancer therapies in the USA: challenges, opportunities and progressShelley A Jazowski, Rahul K Nayak, Stacie B DusetzinaNature Reviews. Clinical Oncology|September 24, 2024
Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of responseChristopher J M Williams, Allyson M Peddle, Pashtoon M Kasi, et al.Nature Reviews. Clinical Oncology|February 18, 2025
Outcome correlates of approved CD19-targeted CAR T cells for large B cell lymphomaTamara J Bock, Chanukya K Colonne, Salvatore Fiorenza, et al.Nature Reviews. Clinical Oncology|November 28, 2022
Criteria for the translation of radiomics into clinically useful testsErich P Huang, James P B O'Connor, Lisa M McShane, et al.Nature Reviews. Clinical Oncology|July 21, 2021
Understanding and overcoming resistance to PARP inhibitors in cancer therapyMariana Paes Dias, Sarah C Moser, Shridar Ganesan, et al.Nature Reviews. Clinical Oncology|March 20, 2013
Adaptive designs for dual-agent phase I dose-escalation studiesJennifer A Harrington, Graham M Wheeler, Michael J Sweeting, et al.Nature Reviews. Clinical Oncology|April 3, 2013
Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptorsJames N Kochenderfer, Steven A RosenbergNature Reviews. Clinical Oncology|July 25, 2013
Image-guided cancer surgery using near-infrared fluorescenceAlexander L Vahrmeijer, Merlijn Hutteman, Joost R van der Vorst, et al.Pageof 97